
Join to view full profile
165 Cambridge StSte 302Boston, MA 02114
Phone+1 802-338-7163
Dr. Kalim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sahir Kalim is a nephrologist, physician-scientist, and Associate Professor of Medicine at Harvard Medical School. He serves as Co-Director of the Kidney Research Center at Massachusetts General Hospital, where he leads clinical and translational research focused on chronic kidney disease, diabetes, biomarkers, and precision medicine.
Dr. Kalim is internationally recognized for his work on protein carbamylation and its role in kidney disease, as well as for studies aimed at improving the assessment of glycemic control in patients with chronic kidney disease. His NIH-funded research integrates biomarker discovery, epidemiology, clinical trials, and advanced predictive modeling to better understand disease mechanisms and improve patient care.
In addition to a broad clinical practice in nephrology, Dr. Kalim has authored numerous peer-reviewed publications, invited reviews, and book chapters, and has served in leadership roles for national and international kidney research initiatives. He is committed to mentoring the next generation of clinician-investigators and advancing innovations that bridge laboratory discovery with patient-centered care.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2013 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2007 - 2010
University of Vermont College of MedicineClass of 2007
Certifications & Licensure
MA State Medical License 2013 - 2027
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis.Sagar U Nigwekar, Laura M Dember, Sahir Kalim, David M Charytan, Natalie Kuzla
Clinical Journal of the American Society of Nephrology. 2026-10-01 - Carbamylation as a Novel Marker of Coronary Artery Calcification in People With CKD: Findings from a Phenome-Wide Association Study in CRIC.Aya Awwad, Pranav Garimella, Eugene P Rhee, Joachim Janowski, S Ananth Karumanchi
American Journal of Kidney Diseases. 2026-09-21 - End-of-Life Care Patterns by Transplant Eligibility Among Patients With End Stage Kidney Disease.Annie Liu, Jennifer F N Kizza-Brown, Ayman Al Jurdi, Ayesha M Malik, Anushka Dalvi
Journal of Pain and Symptom Management. 2026-09-01
Journal Articles
- Serum Angiopoietin‐2 Predicts Mortality and Kidney Outcomes in Decompensated CirrhosisAndrew S Allegretti, Sagar U Nigwekar, Raymond T Chung, Sahir Kalim, Xavier Vela Parada, Ravi I Thadhani, Guillermo A Ortiz, Samir M Parikh, Hepatology
Press Mentions
Smell Loss Common Among Kidney Disease Patients, Study ShowsAugust 7th, 2017
Glycemic Variability in Diabetes Ups AKI, CKD RisksSeptember 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: